Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases

Diagnostic Comparison and Workflow Evaluation of Whole Body PET-magnetic Resonance and PET-CT With and Without Contrast Media in Patients With Oncologic Diseases

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02316431

Acronym

Workflow

Enrollment

142

Registered

2014-12-12

Start date

2014-12-31

Completion date

2016-12-31

Last updated

2016-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm Staging

Brief summary

Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Male and female patients from 18-90 years * Written informed consent * Patients with a proven or suspected oncological disease referred for a clinically -Indicated PET/CT with of without contrast media

Exclusion criteria

* Pregnant or breast feeding women * Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia) * Inclusion in another clinical trial 30 days prior to inclusion * Age \< 30years * Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia * Known allergies to contrast CT or MRI contrast media * Patients with an glomerular filtration rate of \< 60ml/min/1.73m2

Design outcomes

Primary

Measure	Time frame
Number of patients with correct TNM staging defined with PET/magnetic resonance versus PET/CT	12 month

Secondary

Measure	Time frame
Number of minutes needed per PET/magnetic resonance protocol compared to PET/CT	12 month

Countries

Switzerland

Outcome results